Pathogenesis of Multiple Sclerosis via environmental and genetic dysregulation of N-glycosylation

por Grigorian, Ani, Mkhikian, Haik, Li, Carey F., Newton, Barbara L., Zhou, Raymond W., Demetriou, Michael
Publicado 2012

Family studies of Type 1 diabetes reveal additive and epistatic effects between MGAT1 and three other polymorphisms

por Yu, Zhaoxia, Li, Carey F., Mkhikian, Haik, Zhou, Raymond W., Newton, Barbara L., Demetriou, Michael
Publicado 2014

Hypomorphic MGAT5 polymorphisms promote multiple sclerosis cooperatively with MGAT1 and interleukin-2 and 7 receptor variants

por Li, Carey F., Zhou, Raymond W., Mkhikian, Haik, Newton, Barbara L., Yu, Zhaoxia, Demetriou, Michael
Publicado en J Neuroimmunol (2013)

N-acetylglucosamine drives myelination by triggering oligodendrocyte precursor cell differentiation

por Sy, Michael, Brandt, Alexander U., Lee, Sung-Uk, Newton, Barbara L., Pawling, Judy, Golzar, Autreen, Rahman, Anas M. A., Yu, Zhaoxia, Cooper, Graham, Scheel, Michael, Paul, Friedemann, Dennis, James W., Demetriou, Michael
Publicado en J Biol Chem (2020)

Association of a Marker of N-Acetylglucosamine With Progressive Multiple Sclerosis and Neurodegeneration

por Brandt, Alexander U., Sy, Michael, Bellmann-Strobl, Judith, Newton, Barbara L., Pawling, Judy, Zimmermann, Hanna G., Yu, Zhaoxia, Chien, Claudia, Dörr, Jan, Wuerfel, Jens Th., Dennis, James W., Paul, Friedemann, Demetriou, Michael
Publicado en JAMA Neurol (2021)